Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue

• US 9,545,523 B2
• Filed: 03/14/2013
• Issued: 01/17/2017
• Est. Priority Date: 03/14/2013
• Status: Active Grant

• Current Assignee: ZELTIQ Aesthetics, Inc. (Abbvie Incorporated)
• Original Assignee: ZELTIQ Aesthetics, Inc. (Abbvie Incorporated)
• Inventors: Nanda, Gurvinder Singh
• Primary Examiner(s): BOCKELMAN, MARK
• Application Number:
  US13/830,413
• Publication Number:
  US 20140277219A1
• Time in Patent Office: 1,405 Days
• US Class Current: 1/1
• CPC Class Codes: A61B 18/1402 Probes for open surgery
• CPC Class Codes: A61B 2018/00023 closed, i.e. without wound contact by the fluid
• CPC Class Codes: A61B 2018/00613 Irreversible electroporation reversible electroporation A61N1/327
• CPC Class Codes: A61B 2018/143 multiple needles
• CPC Class Codes: A61B 2018/1475 Electrodes retractable in or deployable from a housing
• CPC Class Codes: A61F 2007/0052 for treatment of skin or hair
• CPC Class Codes: A61F 2007/0056 for cooling
• CPC Class Codes: A61F 2007/0086 with a thermostat
• CPC Class Codes: A61F 2007/0087 Hand-held applicators
• CPC Class Codes: A61F 2007/0093 programmed
• CPC Class Codes: A61F 2007/0239 using vacuum
• CPC Class Codes: A61F 2007/029 Fat cell removal or destruction by non-ablative heat treatment
• CPC Class Codes: A61F 7/02 Compresses or poultices for effecting heating or cooling
• CPC Class Codes: A61N 1/403 for thermotherapy, e.g. hyperthermia

Abstract

Systems and methods that enable tissue cooling applications and delivery of electrical energy to adipose tissue for alteration and reduction of body fat are described herein. Aspects of the disclosure are directed to, for example, temperature-controlled electroporation of subcutaneous lipid-rich cells. Additional aspects of the disclosure are directed to treatment methods for treating a target region of a human subject'"'"'s body to achieve an alteration of subcutaneous adipose tissue. The method can include, for example, removing heat from the target region of the human subject during a treatment process to cool subcutaneous lipid-rich cells in the target region to a temperature below normal body temperature. Furthermore, the method can include delivering energy to the target region to produce an electric field in an amount sufficient to create pores in membranes of the subcutaneous lipid-rich cells that have been cooled to the temperature below normal body temperature.

Claims

1. A system for affecting lipid-rich cells in a region of a human subject'"'"'s body, comprising:

a treatment unit configured to house a coolant;

an energy generating unit;

an applicator in fluid communication with the treatment unit and in electrical communication with the energy generating unit; and

a controller in communication with the treatment unit and the energy generating unit, wherein the controller has memory containing instructions that, when executed by the controller, cause the applicator to;

reduce a temperature of a target region beneath the epidermis of the subject to reduce a temperature of subcutaneous lipid-rich cells in the target region to a second temperature less than 37°

C.; and

after reducing the temperature of the target region, start applying energy across the target region such that the applied energy causes pores to form in membranes of the subcutaneous lipid-rich cells, which are at a temperature lower than 37°

C.

2. The system of claim 1 wherein the instructions cause the applicator to apply voltage across the target region to produce a pulsed electric field in an amount sufficient to form the pores in the membranes of the subcutaneous lipid-rich cells.

3. The system of claim 2 wherein the amount of voltage sufficient to form the pores is approximately 10% to about 30% less than the amount of voltage sufficient to form pores in membranes of the subcutaneous lipid-rich cells prior to reducing the temperature to the second temperature.

4. The system of claim 2 wherein the pulsed electric field is produced in an amount insufficient to form pores in membranes of non-lipid-rich cells in the target region.

5. The system of claim 1 wherein the applicator is configured to apply voltage across the target region to produce a pulsed electric field in an amount sufficient to irreversibly open pores in the membranes of the subcutaneous lipid-rich cells, thereby causing the subcutaneous lipid-rich cells to die.

6. The system of claim 1 wherein reducing a temperature of the target region includes cooling the subcutaneous lipid-rich cells in the target region to a temperature below 10°

C.

7. The system of claim 1 wherein the energy generating unit is a radiofrequency (RF) energy generating unit, wherein the controller is in communication with the RF energy generating unit, and wherein the controller has instructions for causing the applicator to deliver RF energy from the RF energy generating unit to the target region selectively to affect lipid-rich cells in the target region.

8. The system of claim 1 wherein the applicator is configured to apply voltage across the target region at a voltage range from about 50 V to about 900 V.

9. The system of claim 8 wherein the applicator is configured to apply voltage across the target region in pulses of duration ranging from about 1 microsecond to about 1 millisecond.

10. The system of claim 1 wherein the applicator is configured to apply bipolar electrical pulses across the target region.

11. The system of claim 1 wherein the applicator includes a plate electrode in thermal communication with the treatment unit and in electrical communication with the energy generating unit.

12. The system of claim 11 wherein the plate electrode is a first flat plate electrode facing a first direction, wherein the applicator includes a second plate electrode facing a second direction, and wherein the second direction is substantially opposite the first direction.

13. The system of claim 1 wherein the applicator includes a cooling plate in thermal communication with the treatment unit and an electrode array in electrical communication with the energy generating unit, and wherein the electrode array includes a plurality of retractable tissue piercing electrodes.

14. The system of claim 1 wherein the controller has instructions for causing the applicator to maintain the second temperature while applying energy across the target region.

15. The system of claim 1 wherein the controller has instructions for causing the applicator to maintain the second temperature for a period after applying energy across the target region.

16. The system of claim 15 wherein the period is between about 1 minute and about 1 hour.

17. The system of claim 1 wherein the applicator includes one or more thermoelectric elements positioned to provide individually controlled heat exchanging zones while coolant from the treatment unit flows through the applicator.

18. The system of claim 1 wherein the applicator includes one or more thermoelectric elements controlled by the controller and positioned to cool the target region.

19. The system of claim 1 wherein the instructions cause the applicator to

cool the subcutaneous lipid-rich cells from a normal temperature to less than about 10°

C. before forming the pores, and

maintain the temperature of the subcutaneous lipid-rich cells below 10°

C. after forming the pores.

20. A system for affecting subcutaneous tissue in a target region of a human subject'"'"'s body, comprising:

an energy generating unit;

an applicator in electrical communication with the energy generating unit and configured to non-invasively remove heat from the subcutaneous tissue and deliver energy to the target region; and

a controller in communication with the energy generating unit and including memory, the memory containing instructions for causing the system to;

deliver the energy from the applicator to the target region to form pores in membranes of subcutaneous cells of the subcutaneous tissue while the subcutaneous cells are below 37°

C., and

use the applicator to—

reduce a temperature of the subcutaneous tissue from a normal temperature to less than about 37°

C. before forming the pores, and/or

maintain the temperature of the subcutaneous tissue at less than about 37°

C. after forming the pores.

21. The system of claim 20 wherein the applicator is configured to maintain the temperature of the subcutaneous tissue at a temperature below 0°

C. while delivering the energy.

22. The system of claim 20 wherein the applicator is configured to apply one or more of radiofrequency (RF) pulses, ultrasound pulses, high frequency ultrasound (HIFU) phased signals, and microwave pulses.

23. The system of claim 20 wherein the applicator has cooling electrodes which transfer heat away from the target region to reduce the temperature of the target region and which are operable to apply voltage across the target region to produce a pulsed electric field that causes the formation of the pores.

24. A system for affecting subcutaneous tissue in a target region of a human subject'"'"'s body, comprising:

a tissue-cooling applicator configured to monitor the target region and to deliver energy to the target region; and

a controller including memory storing instructions that, when executed by the controller, cause the tissue-cooling applicator to monitor the temperature of the target region,

non-invasively cool the target region to a temperature lower than 20°

C., and

deliver energy from the tissue-cooling applicator to the target region such that the energy causes pores to form in membranes of subcutaneous cells at the target region while the subcutaneous cells are cooler than 37°

C.

25. The system of claim 24 wherein the instructions, when executed by the controller, cause the tissue-cooling applicator to cool and deliver energy to the target region such that subcutaneous lipid-rich cells at the target region are substantially affected while non-lipid-rich cells at the target region are not substantially affected.

26. The system of claim 24 wherein the instructions, when executed by the controller, cause the tissue-cooling applicator to cool the target region for a cooling period between 1 minute and 2 hours and to deliver the energy during the cooling period.

27. The system of claim 24 wherein the instructions, when executed by the controller, cause the tissue-cooling applicator to deliver a sufficient amount of the energy to the target region to cause formation of the pores, which cause the lipid-rich cells to die.

28. The system of claim 24 wherein the controller includes a processor for executing the instructions.